Value-Based Care in 2026: Can Health Systems Keep Up?

For most of the past century, American healthcare has operated on a simple but flawed premise: do more, get paid more. Volume drove revenue. Outcomes were secondary.

What Is Value-Based Care?

 Value-based care, legally formalized in 2010 by the Affordable Care Act, is simple in concept: pay doctors and hospitals based on whether patients get better, not how many appointments they have or tests they run. Good care becomes good business. It sounds obvious, consequently raising an uncomfortable question: why has it taken so long?

How We Got Here

Adoption has been slow for decades, but 2026 feels different. The share of healthcare payments tied to outcomes-based arrangements has doubled since 2022. The Centers for Medicare & Medicaid Services (CMS) set a goal of enrolling every Medicare beneficiary in a value-based relationship by 2030.

 Adoption has been slow for decades, but 2026 feels different. The share of healthcare payments tied to outcomes-based arrangements has doubled since 2022. CMS set a goal of enrolling every Medicare beneficiary in a value-based relationship by 2030, and while the current administration hasn't re-upped that target, the direction has remained consistent across administrations for over 15 years. Commercial insurers followed. For most organizations, opting out is no longer realistic.

What's In It For Providers?

 On the surface, value-based care asks a lot of providers: more accountability, and a payment model that can penalize them for what happens outside their walls.

But for providers who already deliver efficient care, it can be lucrative. Under the traditional model, a doctor who keeps patients healthy generates fewer visits and fewer bills. Under value-based care, that same doctor gets rewarded for quality, not quantity. Efficiency becomes a profit margin instead of a penalty.

Due to Medicare, fee-for-service is diminishing regardless. As the single largest payer of health benefits in the country, Medicare sets the gravitational pull for the entire industry. When it moves toward value, the rest of the market follows.

 For health systems heavily dependent on Medicare, adapting to value-based contracts isn't optional. It's just a matter of timing. 

For the well-prepared, value-based care turns good medicine into good economics. For the unprepared, it can do the opposite.

So Why Is Progress Uneven?

Despite the momentum, just one in five healthcare executives believes the industry has made meaningful progress on value-based care in the past two years. This is down from 40% two years ago. More health systems are implementing this model, but they're also struggling to make it work.

Part of the problem is that "value-based care" doesn't have a standardized compensation model. It covers a wide spectrum from a small quality bonus on top of a standard contract to a model where a health system receives a fixed payment per patient per year and owns the financial consequences.

Though many health systems are adopting value-based care, they may be sitting on the cautious end with minimal implementation.

The Questions Worth Asking

The direction healthcare is going isn't in dispute. What's far less understood is what separates the organizations that make it work from those that don't.

• For providers, the gap often comes down to data and preparation, the ability to identify high-risk patients before they become expensive, and the care coordination infrastructure to act on it.

• For payers, it's about structuring contracts that genuinely change provider behavior without triggering backlash or gaming.

• For the health tech vendors selling into both sides, it means understanding which problems are actually being prioritized and which are just being talked about.

Across the board, the gap between intention and execution is where value-based care stalls. 

The Road Ahead

Value-based care has been debated, piloted, and declared transformative for decades. And yet, if you ask most executives what's actually working in their market, with their payer mix, for their patient population, the answers get vague fast. Everyone in healthcare has an opinion on value-based care, but very few have data. That's exactly where the opportunities lie.

At MDRG, we help healthcare organizations understand not just where the market is heading, but why some players are getting there faster.  If a value-based care strategy is on your agenda, get in touch with us today. 

Data references: Sage Growth Partners (2025); Innovaccer / NAACOS State and Science of VBC 2025; Advisory Board; CMS Innovation Center.